Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study

ConclusionsSHP465 MAS was superior to placebo in reducing ADHD symptoms, with a safety profile consistent with other long-acting stimulants.ClinicalTrials.gov Registry Number: NCT02604407.

Source: CNS Drugs - July 15, 2017 Category: Neurology Source Type: research